tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Shin, 17 are a BUY (41.46%), 24 are a HOLD (58.54%).
Analyst James Shin, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 78.81% that have a potential upside of 30.63% achieved within 216 days.
James Shin’s has documented 80 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on STRO, Sutro Biopharma at 25-Mar-2026.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 7/23/2024. The price target of $45 was fulfilled within 3 days with a profit of $4.98 (12.44%) receiving and performance score of 41.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$57.88 (22.51%)
$265
Buy Since 12-Sep-2025
$303
$45.88 (17.84%)
$298
26 days ago
(20-Aug-2026)
2/8 (25%)
$41.17 (15.72%)
35
Buy Since 08-Dec-2021
$300
$42.88 (16.68%)
$295
29 days ago
(17-Aug-2026)
9/11 (81.82%)
$49.67 (19.84%)
469
Buy Since 23-Jan-2023
$260
$2.88 (1.12%)
$235
1 months 5 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
127
Buy Since 06-Feb-2020
$288
$30.88 (12.01%)
$261
1 months 11 days ago
(04-Aug-2026)
36/37 (97.3%)
$44.2 (18.13%)
434
Which stock is James Shin most bullish on?
What Year was the first public recommendation made by James Shin?
